Trademark Overview
On Friday, June 5, 2026, a trademark application was filed for ENTERALIA with the United States Patent and Trademark Office. The USPTO has given the ENTERALIA trademark a serial number of 79454330. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 16, 2026. This trademark is owned by Nemysis Limited. The ENTERALIA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals; medicines containing iron; oral iron compositions for the treatment of iron deficiency and/or anaemia; medicines containing endopeptidases; oral peptidases compositions for the treatment of gluten intolerance; orally administered enzymatic compositions for the treatment and management of gluten intolerance in patients with celiac disease; pharmaceuticals and medicines for the treatment of nutritional disorders and nutritional deficiencies; dietiary supplements; dietary supplements containing iron; dietary supplements containing folic acid; vitamins.
